Vivos Therapeutics Inc (VVOS) reports strong revenue growth and strategic advancements, despite facing increased net losses and market uncertainties.

The Trump trade looks to have temporarily run out of steam. U.S. stock futures were pointing to losses early on Friday, continuing a drop started the previous day by producer-price inflation data and ...